$SKYE
Skye Bioscience, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
SKYE chart
What traders are saying about $SKYE
Latest postsSkye Bioscience, Inc. news
- Top 5 Healthcare and Biotech Pre-Market Gainers on Tuesday: Co-Diagnostics (NASDAQ:CODX) +29.47%, Skye Bioscience, Inc. (NASDAQ:SKYE) +15.93%, Harrow, Inc. (NASDAQ:HROW) +15.13%, Senseonics (NASDAQ:SENS) +13.27%, IceCure Medical (
Kalkine ·
- Top 5 Pre-Market Gainers Priced Below USD 1.00 on Tuesday: Co-Diagnostics (NASDAQ:CODX) +29.47%, Skye Bioscience, Inc. (NASDAQ:SKYE) +15.93%, Tempest Therapeutics (NASDAQ:TPST) +12.06%, IceCure Medical (NASDAQ:ICCM) +11.87%, Inno
Kalkine ·
- Why Is Skye Bioscience, Inc. (NASDAQ:SKYE) Climbing 15.93% in Pre-Market Trade on Tuesday?
Kalkine ·
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga ·
- Skye Bioscience, Inc. (SKYE) Seasonal returns chart
Yahoo Finance UK ·
- Skye Bioscience Stock Price Forecast. Should You Buy SKYE?
StockInvest.us ·
- Skye Bioscience, Inc. Common Stock (NASDAQ: SKYE) Share Price, SKYE Stock News, SKYE Share Price & Updates
kalkine.ca ·
- SKYE Q3'26 Earnings: EPS estimate is (1.14) USD
TradingView ·
- Skye Bioscience Inc (SKYE) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Fibrex ...
Yahoo Finance ·
- Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
Yahoo Finance ·
- The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea
Yahoo Finance ·
- Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
Yahoo Finance ·
Skye Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$55.9M | -$26.6M | -$37.6M | -$19.5M |
| Diluted EPS | $-1.41 | $-0.73 | $-5.37 | $-8.77 |
| Total assets (year end) | $28.3M | $72.8M | $11.9M | $9.1M |
| Cash and equivalents (year end) | $5.9M | $68.4M | $1.3M | $1.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Skye Bioscience, Inc.
- Ticker
- SKYE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1516551
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC.
Frequently asked questions
What exchange is Skye Bioscience, Inc. listed on?
Skye Bioscience, Inc. trades on the Nasdaq under the ticker symbol SKYE.
What industry is Skye Bioscience, Inc. in?
Skye Bioscience, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Skye Bioscience, Inc. headquartered?
Skye Bioscience, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Skye Bioscience, Inc.'s fiscal year end?
Skye Bioscience, Inc.'s fiscal year ends on December 31.